Showing 241-260 of 639 for: Cochrane Systematic Reviews > Cardiovascular 
- Fibrinolytic agents for peripheral arterial occlusion
Cochrane Systematic Reviews, 18-Dec-2013
Peripheral arterial thrombolysis is used in the management of peripheral arterial ischaemia. Streptokinase was originally used but safety concerns led to a search for other agents. Urokinase and recombinant tissue plasminogen activator (rt-PA) have increa
- Fibrinolytic therapy for intraventricular hemorrhage in adults
Cochrane Systematic Reviews, 22-Jul-2002
Spontaneous or secondary intraventricular hemorrhage is a marker of poor prognosis for hemorrhagic stroke. It can cause hydrocephalus and require ventricular shunt placement, result in permanent neurological deficits or death. Fibrinolytic agents injected
- First‐line drugs for hypertension
Cochrane Systematic Reviews, 18-Apr-2018
This is the first update of a review published in 2009. Sustained moderate to severe elevations in resting blood pressure leads to a critically important clinical question: What class of drug to use first-line? This review attempted to answer that questio
- Fish oil for induction of remission in ulcerative colitis
Cochrane Systematic Reviews, 26-May-2008
Fish oil supplements, which are rich in n-3 fatty acids, may reduce inflammation, decrease the need for anti-inflammatory drugs, and promote normal weight gain in people with ulcerative colitis.
- Fish oil for kidney transplant recipients
Cochrane Systematic Reviews, 18-Aug-2016
Calcineurin inhibitors used in kidney transplantation for immunosuppression have adverse effects that may contribute to nephrotoxicity and increased cardiovascular risk profile. Fish oils are rich in very long chain omega-3 fatty acids, which may reduce n
- Fitness training for cardiorespiratory conditioning after traumatic brain injury
Cochrane Systematic Reviews, 29-Dec-2017
Reduced cardiorespiratory fitness (cardiorespiratory deconditioning) is a common consequence of traumatic brain injury (TBI). Fitness training may be implemented to address this impairment.
- Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism
Cochrane Systematic Reviews, 9-Feb-2017
Low molecular weight heparins (LMWHs) have been shown to be effective and safe in preventing venous thromboembolism (VTE). They may also be effective for the initial treatment of VTE. This is the third update of the Cochrane Review first published in 1999
- Fluids and diuretics for acute ureteric colic
Cochrane Systematic Reviews, 15-Feb-2012
Acute ureteric colic is commonly associated with severe and debilitating pain. Theoretically, increasing fluid flow through the affected kidney might expedite stone passage, thereby improving symptoms more quickly. The efficacy and safety of interventions
- Foam dressings for healing diabetic foot ulcers
Cochrane Systematic Reviews, 6-Jun-2013
Foot ulcers in people with diabetes are a prevalent and serious global health issue. Dressings form a key part of ulcer treatment, with clinicians and patients having many different types to choose from. A clear and current overview of current evidence is
- Force platform feedback for standing balance training after stroke
Cochrane Systematic Reviews, 24-Aug-2008
Standing balance deficits are common in individuals after stroke. One way to address these deficits is to provide the individual with feedback from a force platform while balance activities are performed. The feedback can take visual and/or auditory form.
- Furosemide for prevention of morbidity in indomethacin‐treated infants with patent ductus arteriosus
Cochrane Systematic Reviews, 23-Jul-2001
Inhibition of prostaglandin synthesis mediates closure of the ductus arteriosus and renal side effects after indomethacin administration. Because furosemide increases prostaglandin production, it could potentially help prevent indomethacin-related toxicit
- Gangliosides for acute ischaemic stroke
Cochrane Systematic Reviews, 23-Oct-2001
Gangliosides may have a protective effect on the central and peripheral nervous systems.
- Garlic for peripheral arterial occlusive disease
Cochrane Systematic Reviews, 30-Apr-2013
Commercially available preparations of garlic have been reported to have beneficial effects on some of the risk factors associated with atherosclerosis.
- Garlic for the prevention of cardiovascular morbidity and mortality in hypertensive patients
Cochrane Systematic Reviews, 6-Jul-2012
Garlic is widely used by patients for its blood pressure lowering effects. A meta-analysis published in 2008 concluded that garlic consumption lowers blood pressure in hypertensive and normotensive patients. Therefore, it is important to review the curren
- Ginkgo biloba for acute ischaemic stroke
Cochrane Systematic Reviews, 19-Oct-2005
Ginkgo biloba extract is widely used in the treatment of acute ischaemic stroke in China. We aimed to assess the evidence from randomised controlled trials and quasi-randomised controlled trials on the use of Ginkgo biloba extract in acute ischaemic strok
- Ginkgo biloba for intermittent claudication
Cochrane Systematic Reviews, 7-Jun-2013
People with intermittent claudication (IC) suffer from pain in the muscles of the leg occurring during exercise which is relieved by a short period of rest. Symptomatic relief can be achieved by (supervised) exercise therapy and pharmacological treatments
- Glucagon-like peptide analogues for type 2 diabetes mellitus
Cochrane Systematic Reviews, 23-Jul-2013
Glucagon-like peptide analogues are a new class of drugs used in the treatment of type 2 diabetes that mimic the endogenous hormone glucagon-like peptide 1 (GLP-1). GLP-1 is an incretin, a gastrointestinal hormone that is released into the circulation in
- Glycerol for acute stroke
Cochrane Systematic Reviews, 19-Apr-2004
Brain oedema is a major cause of early death after stroke. A 10% solution of glycerol is a hyperosmolar agent that is claimed to reduce brain oedema.
- Glycoprotein IIb-IIIa inhibitors for acute ischaemic stroke
Cochrane Systematic Reviews, 18-Feb-2014
Glycoprotein (GP) IIb-IIIa inhibitors are antiplatelet agents that act by antagonising GP IIb-IIIa receptors on the platelet surface and block the final common pathway to platelet aggregation by preventing the binding of fibrinogen molecules that form bri
- Graduated compression stockings for prevention of deep vein thrombosis
Cochrane Systematic Reviews, 3-Nov-2018
Hospitalised patients are at increased risk of developing deep vein thrombosis (DVT) in the lower limb and pelvic veins, on a background of prolonged immobilisation associated with their medical or surgical illness. Patients with DVT are at increased risk
